2-[(2-NITROPHENYL)-1-HYDROXYIMINOMETHYL)]-3-HYDROXY-CYCLOHEX-2-ENONE
Compound with spectra: 1 NMR
![2-[(2-NITROPHENYL)-1-HYDROXYIMINOMETHYL)]-3-HYDROXY-CYCLOHEX-2-ENONE](/api/compound/G3D4c5ysEgt.png?ph=true&h=300&w=458 "2-[(2-NITROPHENYL)-1-HYDROXYIMINOMETHYL)]-3-HYDROXY-CYCLOHEX-2-ENONE")
| SpectraBase Compound ID | G3D4c5ysEgt |
|---|---|
| InChI | InChI=1S/C13H12N2O5/c16-10-6-3-7-11(17)12(10)13(14-18)8-4-1-2-5-9(8)15(19)20/h1-2,4-5,16,18H,3,6-7H2/b14-13- |
| InChIKey | RJUFXDQGPLVSQT-YPKPFQOOSA-N |
| Mol Weight | 276.25 g/mol |
| Molecular Formula | C13H12N2O5 |
| Exact Mass | 276.074621 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-Cyclohexen-1-one, 2-[1-[(2-fluoroethoxy)imino]butyl]-3-hydroxy-5-(2-methyl-4-thiazolyl) -
2-Cyclohexen-1-one, 2-[1-[[[4-(4-fluorophenyl)-3-pentenyl]oxy]imino]butyl]-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)-
2-Cyclohexen-1-one, 2-[1-[[[4-(3,4-dichlorophenyl)-2-butenyl]oxy]imino]butyl]-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)-
2,3,6,7,8,9-HEXAHYDRO-8,8-DIMETHYL-5-PHENYL-1H-1,4-BENZODIAZEPIN-6-ONE-HYDROCHLORIDE
2-Methyl-3-(4-nitro-benzoyl)-4a,8a-dihydro-[1,4]naphthoquinone
2-Cyclohexen-1-one, 5-[4,5-dihydro-3-(1-methylethyl)-5-isoxazolyl]-3-hydroxy-2-[1-[(2-propenyloxy)imino]butyl]-
2-Cyclohexen-1-one, 2-[1-(ethoxyimino-propyl]-3-hydroxy-5-(3-nitrophenyl)-, benzyl-trimethylammonium, salt
2-Cyclohexen-1-one, 3-hydroxy-5-(3-methyl-5-isoxazolyl)-2-[1-[(2-propenyloxy)imino]butyl] -
Formamide, N-[3-[4-[1-(ethoxyimino)butyl]-3-hydroxy-5-oxo-3-cyclohexen-1-yl]phenyl]-
2-Cyclohexen-1-one, 3-hydroxy-5-(3-nitrophenyl)-2-[1-[(2-propenyloxy)imino]propyl]-
| Title | Journal or Book | Year |
|---|---|---|
| Mode of Action of 4-Hydroxyphenylpyruvate Dioxygenase Inhibition by Triketone-type Inhibitors | Journal of Medicinal Chemistry | 2002 |